Results 141 to 150 of about 67,878 (296)

The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma

, 2016
Shigeo Hashimoto, Takashi Kuroha, Toshio Yano, Naoko Sato, Tatsuo Furukawa   +4 more
openalex   +2 more sources

Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long‐term results [PDF]

, 2007
Marzia Lazzerini, Stefano Martelossi, Federico Marchetti, Aldo Scabar, Fulvio Bradaschia, Luca Ronfani, Alessandro Ventura   +6 more
openalex   +1 more source

Systemic immunomodulating therapies for epidermal necrolysis (Stevens‐Johnson syndrome/toxic epidermal necrolysis): A systematic review and meta‐analysis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 34-42, January 2026.
Summary Background and Objectives Epidermal necrolysis is a rare but severe cutaneous reaction with high mortality. Limited evidence exists regarding the efficacy of systemic immunomodulatory therapies (SITs). Our systematic review aimed to compare SITs with supportive care or one another.
Ruben Heuer, Maren Paulmann, Maja Mockenhaupt, Alexander Nast   +3 more
wiley   +1 more source

Long‐term results of single‐agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma

, 2010
Kristen Detweiler‐Short, Suzanne R. Hayman, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Shaji Kumar, Steven R. Zeldenrust, Stephen J. Russell, John A. Lust, Robert A. Kyle, Philip R. Greipp, Thomas E. Witzig, S. Vincent Rajkumar   +12 more
openalex   +2 more sources

A Case of Refractory Henoch-Schonlein Purpura Treated with Thalidomide [PDF]

, 2002
Soo Jeong Choi, Sung Kyu Park, Wan Sik Uhm, Dae Sik Hong, Hee Sook Park, Young Lip Park, Kye Won Kwon   +6 more
openalex   +1 more source

Systemische immunmodulierende Therapien der epidermalen Nekrolyse (Stevens‐Johnson‐Syndrom/toxisch epidermale Nekrolyse): Systematische Übersicht und Metaanalyse

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 34-43, January 2026.
Zusammenfassung Hintergrund und Ziele Epidermale Nekrolyse ist eine seltene, aber schwere Hautreaktion mit hoher Letalität. Zur Wirksamkeit systemischer immunmodulatorischer Therapien (SIT) liegt wenig Evidenz vor. Ziel unserer systematischen Übersichtsarbeit war der Vergleich von SIT mit supportiver Therapie oder untereinander.
Ruben Heuer, Maren Paulmann, Maja Mockenhaupt, Alexander Nast   +3 more
wiley   +1 more source

Do Wortmannin and Thalidomide induce apoptosis by autophagy inhibition in 4T1 breast cancer cells in vitro and in vivo?

, 2021
Elgin Türköz Uluer, Pınar Kılıçaslan Sönmez, Damla Akoğulları, Melike Özgül Önal, Gamze Tanrιöver, Sevinç İnan   +5 more
openalex   +1 more source

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma [PDF]

, 2000

openalex   +1 more source

Combination Indices (CI) of LEN, THAL or POM in combination with GCV at 7 days. from Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein–Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression

, 2023
Richard J. Jones, Tawin Iempridee, Xiaobin Wang, Hans C. Lee, Janet E. Mertz, Shannon C. Kenney, Heather C. Lin, Veerabhadran Baladandayuthapani, William O. Dawson, Jatin J. Shah, Donna M. Weber, Robert Z. Orlowski   +11 more
openalex   +1 more source

Ubiquitination dynamics in human tumour viruses: Viral infection, oncogenesis and antiviral therapy

The FEBS Journal, Volume 293, Issue 2, Page 325-347, January 2026.
The ubiquitin system is essential for cellular homeostasis and regulates many processes. Viruses, including oncogenic ones, exploit or evade this system to survive and replicate. This review explores how human tumour viruses manipulate the ubiquitination system to complete their life cycle, evade immunity and promote cancer.
Oscar Trejo‐Cerro, Martina Bergant Marušič, Justyna Broniarczyk   +2 more
wiley   +1 more source